The results mentioned above indicate that the bradycardia effect of METmay be mediated by mu 2 subtype of opiate receptors instead of mu 1;
BACKGROUND: As unspecific antagonist of opiate receptor, naloxone is widely used for multiple diseases which are related with abnormal release of endogenous opium.
